Lonza Group reported CHF645M in Operating Profit for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Akzo Nobel AKZA:NA EUR 168M 37M
Alcon AG ALC:SW USD 205M 5M
AstraZeneca AZN:LN USD 1.25B 706M
Bayer BAYN:GR EUR 1.2B 1.03B
Covestro 1COV:GR EUR 66M 241M
Fresenius FRE:GR EUR 887M 42M
Fresenius Medical Care FME:GR EUR 472M 131M
Genmab GEN:DC DKK 1.93B 684M
Givaudan GIVN:VX CHF 631M 155M
GlaxoSmithKline GSK:LN GBP 1.19B 110M
Hikma Pharmaceutical HIK:LN USD 249M 6M
Johnson Matthey JMAT:LN GBP 211M 24M
Merck MRK:GR EUR 1.23B 57M
Novartis NOVN:VX USD 2.17B 60M
Philips PHIA:NA EUR -1529000000 1.54B
Roche Holding ROG:VX 11.55B 3.47B
Smith & Nephew PLC SN/:LN 242M 187M
Solvay SOLB:BB EUR 527M 368M
William Demant Holding WDH:DC DKK 1.59B 219M